This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Choudhury A, Liang JC, Thomas EK, Flores-Romo L, Xie QS, Agusala K, Sutaria S, Sinha I, Champlin RE, Claxton DF . Dendritic cells derived in vitro from acute myelogenous leukemia cells stimulate autologous, antileukemic T-cell responses Blood 1999 93: 780–786
Choudhury A, Toubert A, Sutaria S, Charron D, Champlin RE, Claxton DF . Human leukemia-derived dendritic cells – ex vivo development of specific antileukemic cytotoxicity Crit Rev Immunol 1998 18: 121–131
Charbonnier A, Gaugler B, Sainty D, Lafage-Pochitaloff M, Olive D . Human acute myeloblastic leukemia cells differentiate in vitro into mature dendritic cells and induce the differentiation of cytotoxic T cells against autologous leukemias Eur J Immunol 1999 29: 2567–2578
Brouwer RE, van der HM, Kluin-Nelemans HC, Zelderen-Bhola S, Willemze R, Falkenburg JH . The generation of dendritic-like cells with increased allostimulatory function from acute myeloid leukemia cells of various FAB subclasses Hum Immunol 2000 61: 565–574
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Claxton, D., Choudhury, A. Potential for therapy with AML-derived dendritic cells. Leukemia 15, 668–669 (2001). https://doi.org/10.1038/sj.leu.2402056
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.leu.2402056
This article is cited by
-
The Efficient Generation of Immunocompetent Dendritic Cells from Leukemic Blasts in Acute Myeloid Leukemia: A Local Experience
Pathology & Oncology Research (2009)